6Sokal JE. Incidence of malignancy in toxic and nontoxic nodular goiter. JAMA, 1954, 154: 1321.
7Yasenin G, Tunca FT, Boztepe HR, et al. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic muhinodular goiter, and toxic adenoma. Surgery, 2008, 144 : 1028-1036.
8Vaiana R, Cappelli C, Perini P, et al. Hyperthyroidism and concurrent thyroid cancer. Tumor, 1999, 85: 247-252.
9Usha A, Joseph, Satish G. Graves disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease. Clin Nucl Med, 1995, 20: 416-418.
10Chao TC, Lin JD, Jeng LB, et al. Thyroid cancer with concurrent hyperthyroidism. Arch Surg, 1999, 134: 130-134.
